Magnesium intake and risk of amyotrophic lateral sclerosis: Results from five large cohort studies

References

• Moshfegh A, Golman J, Auhja J, Rhodes D, Lacomb R. What we eat in America, NHANES 2005 − 2006: usual intakes from food and water compared to 1997 Dietary Reference Intakes for vitamin D, calcium, phosphorus and magnesium. Washington, DC: US Department of Agriculture, Agricultural Research Service; 2009.
   Google Scholar
• King DE, Mainous AG 3rd,Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nut. 2005;24:166–71.
   PubMed Web of Science ®Google Scholar
• Yase Y. The pathogenesis of amyotrophic lateral sclerosis. Lancet. 1972;2:292–6.
   PubMed Web of Science ®Google Scholar
• Yasui M, Ota K, Yoshida M. Effects of low calcium and magnesium dietary intake on the central nervous system tissues of rats and calcium-magnesium related disorders in the amyotrophic lateral sclerosis focus in the Kii Peninsula of Japan. Magnes Res. 1997;10:39–50.
   PubMed Web of Science ®Google Scholar
• Longnecker MP, Kamel F, Umbach DM, Munsat TL, Shefner JM, Lansdell LW, et al. Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2000;19: 210–6.
   PubMed Web of Science ®Google Scholar
• Pamphlett R, Todd E, Vink R, McQuilty R, Cheema SS. Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS. J Neurol Sci. 2003;216:95–8.
   PubMedGoogle Scholar
• Colditz GA, Manson JE, Hankinson SE. The Nurses’ Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6:49–62.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464–8.
   PubMed Web of Science ®Google Scholar
• Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002; 94:2490–501.
   PubMed Web of Science ®Google Scholar
• Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151:346–57.
   PubMed Web of Science ®Google Scholar
• Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health/American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001;154:1119–25.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160:26–33.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 − 1998. Neurology.2002;59:280–2.
   Google Scholar
• Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle & Nerve. 2002;25:709–14.
   PubMed Web of Science ®Google Scholar
• Flagg EW, Coates RJ, Calle EE, Potischman N, Thun MJ. Validation of the American Cancer Society Cancer Prevention Study II Nutrition Survey Cohort Food Frequency Questionnaire. Epidemiology. 2000;11:462–8.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semi-quantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1114–26; discussion 27 − 36.
   PubMed Web of Science ®Google Scholar
• Chiuve SE, Korngold EC, Januzzi JL Jr, Gantzer ML, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93: 253–60.
   PubMed Web of Science ®Google Scholar
• Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124: 17–27.
   PubMed Web of Science ®Google Scholar
• Willett W. Nutritional Epidemiology. 2nd edn. New York: Oxford University Press; 1998.
   Google Scholar
• Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd edn. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
   Google Scholar
• Wang H, O’Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of five prospective cohorts. Arch Neurol. 2011;68:207–13.
   PubMed Web of Science ®Google Scholar
• Wang H, O’Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Schatzkin A, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from five prospective cohort studies. Am J Epidemiol. 2011; 173:595–602.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
   PubMed Web of Science ®Google Scholar
• Dai Q, Motley SS, Smith JA Jr, Concepcion R, Barocas D, Byerly S, et al. Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate cancer. PloS One. 2011;6:e18237.
   PubMed Web of Science ®Google Scholar
• Hollifield JW. Thiazide treatment of hypertension: effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. Am J Med . 1986;80:8–12.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Armon C. An evidence based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003; 22:217–28.
   PubMed Web of Science ®Google Scholar
• Chio A. Risk factors in the early diagnosis of ALS: European epidemiological studies. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 1):S13–8.
   PubMedGoogle Scholar
• Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971;24:5–8.
   PubMedGoogle Scholar
• Hashimoto T, Nishi K, Nagasao J, Tsuji S, Oyanagi K. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons. Brain Res. 2008;1197:143–51.
   PubMed Web of Science ®Google Scholar
• Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell. 2003;114:191–200.
   PubMed Web of Science ®Google Scholar
• Chubanov V, Waldegger S, Mederos y Schnitzler M, Vitzthum H, Sassen MC, Seyberth HW, et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci USA. 2004;101:2894–9.
   PubMedGoogle Scholar
• Hermosura MC, Nayakanti H, Dorovkov MV, Calderon FR, Ryazanov AG, Haymer DS, et al. A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proc Natl Acad Sci U S A. 2005;102:11510–5.
   PubMed Web of Science ®Google Scholar
• Kamel F, Umbach DM, Hu H, Munsat TL, Shefner JM, Taylor JA, et al. Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2:195–201.
   PubMed Web of Science ®Google Scholar
• Fang F, Kwee LC, Allen KD, Umbach DM, Ye W, Watson M, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010; 171:1126–33.
   PubMed Web of Science ®Google Scholar
• Tiffany-Castiglioni E, Qian Y. ER chaperone-metal interactions: links to protein folding disorders. Neurotoxicology. 2012;33:545–57.
   PubMedGoogle Scholar